Ring Therapeutics
Christopher Reardon currently serves as a Research Associate II in Vector Biology at Ring Therapeutics since October 2023. Prior to this role, Christopher worked at Massachusetts General Hospital from June 2022 to October 2023 as a Research Technician and Clinical Research Coordinator. Earlier experience includes serving as a Teaching Assistant for courses in Introduction to Biology II, Neurobiology, and Genetics at the University of Massachusetts Amherst from September 2021 to May 2022. Christopher Reardon earned a Bachelor of Science degree in Biology from the University of Massachusetts Amherst between September 2018 and May 2022.
This person is not in the org chart
Ring Therapeutics
Ring Therapeutics' Anellogy™ platform aims to usher in a new era of gene therapy using the human commensal virome.